Product
JS015
3 clinical trials
3 indications
Indication
Pancreatic CancerIndication
Advanced Solid TumorIndication
Solid CancerClinical trial
A Phase Ib/II Platform Trial of Newly Emerging Immunotherapy for Pancreatic Cancer TreatmentStatus: Not yet recruiting, Estimated PCD: 2026-04-30
Clinical trial
A Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of JS015 Combination Therapy in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-11-30
Clinical trial
A Phase I Study to Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS015 In Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-01